1. Home
  2. SLN vs PCB Comparison

SLN vs PCB Comparison

Compare SLN & PCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$4.83

Market Cap

318.4M

Sector

Health Care

ML Signal

HOLD

Logo PCB Bancorp

PCB

PCB Bancorp

HOLD

Current Price

$23.43

Market Cap

324.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLN
PCB
Founded
1994
2003
Country
US
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
318.4M
324.9M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SLN
PCB
Price
$4.83
$23.43
Analyst Decision
Buy
Hold
Analyst Count
6
2
Target Price
$39.67
$24.50
AVG Volume (30 Days)
203.2K
18.9K
Earning Date
01-01-0001
04-30-2026
Dividend Yield
N/A
3.79%
EPS Growth
N/A
N/A
EPS
N/A
1.94
Revenue
N/A
$2,774,000.00
Revenue This Year
N/A
$13.73
Revenue Next Year
N/A
$9.07
P/E Ratio
N/A
$12.01
Revenue Growth
N/A
4.68
52 Week Low
$1.97
$16.02
52 Week High
$7.78
$24.20

Technical Indicators

Market Signals
Indicator
SLN
PCB
Relative Strength Index (RSI) 47.85 56.67
Support Level $4.38 $22.36
Resistance Level $4.97 $23.52
Average True Range (ATR) 0.40 0.63
MACD 0.06 -0.02
Stochastic Oscillator 79.20 63.50

Price Performance

Historical Comparison
SLN
PCB

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

About PCB PCB Bancorp

PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.

Share on Social Networks: